Dynorphin Modulates Ocular Hydrodynamics and Releases Atrial Natriuretic Peptide via Activation of κ-Opioid Receptors-Reference-Cited by-同舟云学术

Dynorphin Modulates Ocular Hydrodynamics and Releases Atrial Natriuretic Peptide via Activation of κ-Opioid Receptors

Published:2002-09 Issue:3 Volume:75 Page:259-270
ISSN:0014-4835
Container-title:Experimental Eye Research
language:en
Short-container-title:Experimental Eye Research

Author:

Russell Karen R.M.,Potter David E.

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference49 articles.

1. Stimulation of guanosine-5′-O-(3-[35S]Thio)Triphosphate binding by endogenous opioids acting at a cloned mu receptor;Alt;J. Pharmacol. Exp. Ther,1998

2. Secretion of atrial and brain natriuretic peptides from human cardiac atrial explants in culture: effect of dynorphin;Ationu;Cardioscience,1994

3. Effects of niravoline (RU 51599) a selective kappa-opioid receptor agonist on intracranial pressure in gradually expanding extradural mass lesion;Bemana;J. Neurotrauma,1998

4. Localization and characterization of specific receptors for atrial natriuretic factor in the ciliary processes of the eye;Bianchi;Curr. Eye Res,1986

5. Clinical evaluation of the circulation of aqueous humor;Brubaker,1986

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of kappa opioid receptors in developing rat brain – Implications for perinatal buprenorphine exposure;Reproductive Toxicology;2018-06

2. Delta Opioids: Neuroprotective Roles in Preclinical Studies;Journal of Ocular Pharmacology and Therapeutics;2018-03

3. Determining Pharmacological Selectivity of the Kappa Opioid Receptor Antagonist LY2456302 Using Pupillometry as a Translational Biomarker in Rat and Human;International Journal of Neuropsychopharmacology;2015-01-29

4. Influence of the Hypothalamic Arcuate Nucleus on Intraocular Pressure and the Role of Opioid Peptides;PLoS ONE;2014-04-01

5. Non-Analgesic Effects of Opioids: Neuroprotection in the Retina;Current Pharmaceutical Design;2012-10-18